SMYD3 and breast carcinoma: SET and MYND domain-containing protein 3 (SMYD3), a member of the SET and MYND domain family of lysine methyltransferases, is overexpressed in various types of human cancers, including prostate cancer, breast cancer, colon cancer, colorectal cancer, ovarian cancer, and HCC [6–10].